Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out
Title: | Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out |
---|---|
Authors: | Proto, C., Ferrara, R., Signorelli, D., Lo Russo, G., Galli, G., Imbimbo, M., Prelaj, A., Zilembo, N., Ganzinelli, M., Pallavicini, L.M., De Simone, I., Colombo, M.P., Sica, A., Torri, V., Garassino, M.C. |
Source: | In Cancer Treatment Reviews May 2019 75:39-51 |
Database: | ScienceDirect |
ISSN: | 03057372 |
---|---|
DOI: | 10.1016/j.ctrv.2019.03.004 |
Published in: | Cancer Treatment Reviews |
Language: | English |